Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 3034701 dose-finding study in adults with obesity or overweight
CTR20262605Phase 2Active
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of BI 3034701 in obesity, Overweight, sponsored by Boehringer Ingelheim. Started Jul 2026; status: active.
02
Drugs
BI 3034701
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20262605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262605.